Human cardiovascular progenitor cells develop from a KDR+ embryonic-stem-cell-derived population
The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
The functional heart is comprised of distinct mesoderm-derived lineages including cardiomyocytes, endothelial cells and vascular smooth muscle cells. Studies in the mouse embryo and the mouse embryonic stem cell differentiation model have provided evidence indicating that these three lineages develop from a common Flk-1(+) (kinase insert domain protein receptor, also known as Kdr) cardiovascular progenitor that represents one of the earliest stages in mesoderm specification to the cardiovascular lineages. To determine whether a comparable progenitor is present during human cardiogenesis, we analysed the development of the cardiovascular lineages in human embryonic stem cell differentiation cultures. Here we show that after induction with combinations of activin A, bone morphogenetic protein 4 (BMP4), basic fibroblast growth factor (bFGF, also known as FGF2), vascular endothelial growth factor (VEGF, also known as VEGFA) and dickkopf homolog 1 (DKK1) in serum-free media, human embryonic-stem-cell-derived embryoid bodies generate a KDR(low)/C-KIT(CD117)(neg) population that displays cardiac, endothelial and vascular smooth muscle potential in vitro and, after transplantation, in vivo. When plated in monolayer cultures, these KDR(low)/C-KIT(neg) cells differentiate to generate populations consisting of greater than 50% contracting cardiomyocytes. Populations derived from the KDR(low)/C-KIT(neg) fraction give rise to colonies that contain all three lineages when plated in methylcellulose cultures. Results from limiting dilution studies and cell-mixing experiments support the interpretation that these colonies are clones, indicating that they develop from a cardiovascular colony-forming cell. Together, these findings identify a human cardiovascular progenitor that defines one of the earliest stages of human cardiac development.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“CMs can reliably be derived from human embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs) using protocols that involve timed application of GFs or small molecules, that are designed to recapitulate developmental pathways.”
From Cardiovascular disease models: A game changing paradigm in drug discovery and screening (2019) · cites this paper as [148]
Citations
Cites
Laflamme, M. A., Chen, K. Y., Naumova, A. V., Muskheli, V., Fugate, J. A., Dupras, S. K., Reinecke, H., Xu, C., Hassanipour, M., Police, S., et al. (2007) · Nature Biotechnology · doi:10.1038/nbt1327 · Cited by 2,206
Bone morphogenetic protein-4 is required for mesoderm formation and patterning in the mouse.
Winnier, G., Blessing, M., Labosky, P. A., & Hogan, B. L. (1995) · Genes & Development · doi:10.1101/gad.9.17.2105 · Cited by 1,788
Cai, C.-L., Liang, X., Shi, Y., Chu, P.-H., Pfaff, S. L., Chen, J., & Evans, S. (2003) · Developmental Cell · doi:10.1016/s1534-5807(03)00363-0 · Cited by 1,610
Moretti, A., Caron, L., Nakano, A., Lam, J. T., Bernshausen, A., Chen, Y., Qyang, Y., Bu, L., Sasaki, M., Martin-Puig, S., et al. (2006) · Cell · doi:10.1016/j.cell.2006.10.029 · Cited by 1,038
Bearzi, C., Rota, M., Hosoda, T., Tillmanns, J., Nascimbene, A., De Angelis, A., Yasuzawa-Amano, S., Trofimova, I., Siggins, R. W., LeCapitaine, N., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0706760104 · Cited by 980
Requirement for Wnt3 in vertebrate axis formation
Liu, P., Wakamiya, M., Shea, M. J., Albrecht, U., Behringer, R. R., & Bradley, A. (1999) · Nature Genetics · doi:10.1038/11932 · Cited by 901
Lints, T. J., Parsons, L. M., Hartley, L., Lyons, I., & Harvey, R. P. (1993) · Development · doi:10.1242/dev.119.2.419 · Cited by 861
Conlon, F. L., Lyons, K. M., Takaesu, N., Barth, K. S., Kispert, A., Herrmann, B., & Robertson, E. J. (1994) · Development · doi:10.1242/dev.120.7.1919 · Cited by 770
Kattman, S. J., Huber, T. L., & Keller, G. M. (2006) · Developmental Cell · doi:10.1016/j.devcel.2006.10.002 · Cited by 729
Self-citationRole of the NF-ATc transcription factor in morphogenesis of cardiac valves and septum
de la Pompa, J. L., Timmerman, L. A., Takimoto, H., Yoshida, H., Elia, A. J., Samper, E., Potter, J., Wakeham, A., Marengere, L., Langille, B. L., et al. (1998) · Nature · doi:10.1038/32419 · Cited by 660
Cited by
Items 901–1,000 of 1,000
Malecki, M. (2013) · Journal of Stem Cell Research & Therapy · doi:10.4172/2157-7633.1000138 · Cited by 11
Systems for the Functional Evaluation of Human Heart Tissues Derived from Pluripotent Stem Cells
Murata, K., & Masumoto, H. (2022) · Stem Cells · doi:10.1093/stmcls/sxac022 · Cited by 11
Predicting individual-specific cardiotoxicity responses induced by tyrosine kinase inhibitors
Shim, J. V., Xiong, Y., Dhanan, P., Dariolli, R., Azeloglu, E. U., Hu, B., Jayaraman, G., Schaniel, C., Birtwistle, M. R., Iyengar, R., et al. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1158222 · Cited by 15
“In brief, iPSCs were differentiated using an established protocol (Yang et al., 2008; Kattman et al., 2011) that included generation of embryoid bodies and sequential activation and inhibition of WNT signaling.”
MethodZhou, Y., Fujisawa, I., Ino, K., Matsue, T., & Shiku, H. (2015) · Molecular BioSystems · doi:10.1039/c5mb00340g · Cited by 11
Talavera‐Adame, D., Gupta, A., Kurtovic, S., Chaiboonma, K. L., Arumugaswami, V., & Dafoe, D. C. (2013) · Stem Cells and Development · doi:10.1089/scd.2013.0013 · Cited by 11
Kong, C., Chen, S., Geng, L., Shum, A. M. Y., Sun, D. B., & Li, R. A. (2017) · Stem Cell Research · doi:10.1016/j.scr.2017.01.003 · Cited by 11
Rabbit induced pluripotent stem cells retain capability of in vitro cardiac differentiation
Phakdeedindan, P., Setthawong, P., Tiptanavattana, N., Rungarunlert, S., Ingrungruanglert, P., Israsena, N., Techakumphu, M., & Tharasanit, T. (2018) · EXPERIMENTAL ANIMALS · doi:10.1538/expanim.18-0074 · Cited by 11
An Overview of Pluripotent Stem Cells
Bhartiya, D., Nagvenkar, P. V., Sriraman, K., & Shaikh, A. (2013) · InTech eBooks · doi:10.5772/55130 · Cited by 13
Alsaeedi, H. A., Lam, C., Koh, A. E.-H., Teh, S. W., Mok, P. L., Higuchi, A., Then, K. Y., Bastion, M.-L. C., Alzahrani, B., Farhana, A., et al. (2019) · Journal of Photochemistry and Photobiology B Biology · doi:10.1016/j.jphotobiol.2019.111727 · Cited by 11
Yap, L., Wang, J., Moreno‐Moral, A., Chong, L. Y., Sun, Y., Harmston, N., Wang, X., Chong, S. Y., Vanezis, K., Öhman, M. K., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.107714 · Cited by 12
Lieu, D. K., Turnbull, I. C., Costa, K. D., & Li, R. A. (2012) · Drug Discovery Today Disease Models · doi:10.1016/j.ddmod.2012.06.002 · Cited by 12
Strategies for future histocompatible stem cell therapy
Nehlin, J. O., & Barington, T. (2009) · Biogerontology · doi:10.1007/s10522-009-9213-7 · Cited by 11
He, Z., Grunewald, M., Dor, Y., & Keshet, E. (2016) · Mechanisms of Development · doi:10.1016/j.mod.2016.10.004 · Cited by 12
Tchao, J., Han, L., Lin, B., Yang, L., & Tobita, K. (2014) · Scientific Reports · doi:10.1038/srep06614 · Cited by 11
Self-citationStrategies for enrichment and selection of stem cell-derived tissue precursors
Bernstein, H. S., & Hyun, W. C. (2012) · Stem Cell Research & Therapy · doi:10.1186/scrt108 · Cited by 10
“BMP4, BMP4/bFGF/Activin A,VEGF/DKK1, VEGF/DKK1/bFGF Cardiomyocytes [26]”
MethodLeukemia Inhibitory Factor Increases Survival of Pluripotent Stem Cell-Derived Cardiomyocytes
Blüguermann, C., Romorini, L., Evseenko, D. A., Garate, X., Neiman, G., Sevlever, G. E., Scassa, M. É., & Miriuka, S. (2017) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-017-9769-6 · Cited by 10
“The differentiation protocol used in the present study is a combination of two previously reported protocols [20, 21].”
MethodEllis, M. E., Harris, B. N., Hashemi, M., Harvell, B. J., Bush, M. Z., Hicks, E. E., Finklea, F. B., Wang, E. M., Nataraj, R., Young, N. P., et al. (2022) · Tissue Engineering Part A · doi:10.1089/ten.tea.2022.0107 · Cited by 10
Kent, G. M., Atkins, M. H., Lung, B., Nikitina, A., Fernandes, I. M., Kwan, J. J., Andrews, T. S., MacParland, S. A., Keller, G. M., & Gage, B. K. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.114629 · Cited by 11
Self-citationWang, X., Liu, X., Zhang, H., Nie, L., Chen, M., & Ding, Z. (2015) · International Journal of Cardiology · doi:10.1016/j.ijcard.2015.09.002 · Cited by 10
Höbaus, J., Heher, P., Gottschamel, T., Scheinast, M., Auner, H., Walder, D., Wiedner, M., Taubenschmid, J., Miksch, M., Sauer, T., et al. (2013) · Cells Tissues Organs · doi:10.1159/000345804 · Cited by 11
Lee, T., Kang, S., Jeong, G., Yoon, J., Bhang, S. H., Oh, J., & Kim, B. (2014) · Tissue Engineering Part A · doi:10.1089/ten.tea.2014.0015 · Cited by 10
“EB, EB-MS, and EB-AuMS were induced to undergo cardiomyogenic differentiation, as previously described.(14) Briefly, EBs, EB-MS, and EB-AuMS were transferred to a low-attachment culture dish (BD Bioscience), then treated with the following cytokines: BMP4 (0.”
InfluentialDuelen, R., Gilbert, G., Patel, A. M., de Schaetzen, N., Waele, L. D., Roderick, H. L., Sipido, K. R., Verfaillie, C. M., Buyse, G., Thorrez, L., et al. (2017) · Stem Cells International · doi:10.1155/2017/4651238 · Cited by 12
Generation of PDGFRα+ Cardioblasts from Pluripotent Stem Cells
Hong, S. P., Song, S., Cho, S. W., Lee, S., Koh, B. I., Bae, H., Kim, K. H., Park, J.-S., Do, H., Im, I., et al. (2017) · Scientific Reports · doi:10.1038/srep41840 · Cited by 10
Kimura, M., Furukawa, H., Shoji, M., & Shinozawa, T. (2019) · Journal of Stem Cells and Regenerative Medicine · doi:10.46582/jsrm.1502009 · Cited by 10
Validation of reliable safe harbor locus for efficient porcine transgenesis
Ma, X., Zeng, W., Wang, L., Cheng, R., Zhao, Z., Huang, C., Sun, Z., Tao, P., Wang, T., Zhang, J., et al. (2022) · Functional & Integrative Genomics · doi:10.1007/s10142-022-00859-3 · Cited by 11
Mascheck, L., Sharifpanah, F., Tsang, S. Y., Wartenberg, M., & Sauer, H. (2015) · International Journal of Cardiology · doi:10.1016/j.ijcard.2015.05.019 · Cited by 10
Combined hypoxia and sodium nitrite pretreatment for cardiomyocyte protection in vitro
Hsieh, A., Feric, N. T., & Radisic, M. (2015) · Biotechnology Progress · doi:10.1002/btpr.2039 · Cited by 14
Uses of cardiomyocytes generated from induced pluripotent stem cells
Lu, T., & Yang, L. (2011) · Stem Cell Research & Therapy · doi:10.1186/scrt85 · Cited by 10
“Progress was made by Yang and colleagues in 2008 [36], when a staged protocol was established to induce cardiovascular diff erentiation from hES cells by following the biology of early heart development, which specifi cally yielded over 50% contracting cardiomyocytes after 20 days of diff erentiation (Figure 1a).”
BackgroundSelf-citationLoss of Emp2 compromises cardiogenic differentiation in mouse embryonic stem cells
Liu, Y., Dakou, E., Meng, Y., & Leyns, L. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.02.048 · Cited by 10
Morpho-functional comparison of differentiation protocols to create iPSC-derived cardiomyocytes
Nijak, A., Simons, E., Vandendriessche, B., de Sande, D. V. V., Fransén, E., Sieliwończyk, E., Gucht, I. V., Craenenbroeck, E. M. V., Saenen, J. B., Heidbüchel, H., et al. (2022) · Biology Open · doi:10.1242/bio.059016 · Cited by 10
“…like activin A, bone morphogenetic proteins (BMPs), fibroblast growth factor 2 (FGF2), vascular endothelial growth factor (VEGF), Dickkopf-related protein (DKK) and Wnt agonists and antagonists (Zhang et al., 2012; Yang et al., 2008; Burridge et al., 2011; Lian et al., 2012; Minami et al., 2012).”
Green, M. D., & Snoeck, H. (2011) · BMC Medicine · doi:10.1186/1741-7015-9-51 · Cited by 10
Notch Signaling Commits Mesoderm to the Cardiac LineagePreprint
Bardot, E., Jadhav, B., Wickramasinghe, N. M., Rezza, A., Rendl, M., Sharp, A. J., & Dubois, N. C. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.02.20.958348 · Cited by 12
“3a) (Calderon et al., 2016; Kattman et al., 2011; Lian et al., 2013; Yang et al., 2008).”
BackgroundXiao, J., Ang, J. W., Zhong, X., Wong, D. C. P., Thivakar, T., Yow, I., Lee, C. J. M., Foo, R., Kanchanawong, P., & Low, B. C. (2025) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.4c15459 · Cited by 9
Embryonic Stem Cells for Severe Heart Failure: Why and How?
Menasché, P. (2012) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-012-9356-9 · Cited by 11
“A similar kind of multilineage differentiation has also been described for a population of cells expressing fetal liver kinase-1 and thought to represent early cardiac progenitors whose developmental stage temporally corresponds to their exit from the primitive streak [51]; in this case, the cardiomyogenic differentia…”
BackgroundSirabella, D., Cimetta, E., & Vunjak‐Novakovic, G. (2015) · Experimental Biology and Medicine · doi:10.1177/1535370215589910 · Cited by 12
“EB Activin A, BMP4, bFGF VEGF, DKK1 Yang et al.(26)”
BackgroundMethodInfluentialPreparation of iPS cell-derived CD31+ endothelial cells using three-dimensional suspension culture
Masuda, S., Matsuura, K., & Shimizu, T. (2018) · Regenerative Therapy · doi:10.1016/j.reth.2018.06.004 · Cited by 9
Apela Promotes Cardiomyocyte Differentiation from Transgenic Human Embryonic Stem Cell Lines
Wang, Z., & Huang, J. (2019) · Applied Biochemistry and Biotechnology · doi:10.1007/s12010-019-03012-2 · Cited by 9
Francoeur, N., & Sen, R. (2021) · Journal of Developmental Biology · doi:10.3390/jdb9040040 · Cited by 9
Regenerating Damaged Myocardium: A Review of Stem-Cell Therapies for Heart Failure
Fan, D., Wu, H., Peng, H., Pan, K., & Wu, R. (2021) · Cells · doi:10.3390/cells10113125 · Cited by 10
“Kinase domain receptor 1 (KDR1) is expressed by progenitor cells that beget cardiomyocytes, endothelial c lls, and smooth-muscle cells during development [71], and three distinc patterns of expressio for KDR and C-KIT (a marker for hemangioblast-derived haema opoi tic and vascular progenitor cells) are observed in cel…”
BackgroundInfluentialLiu, J., Zhang, Y., Wu, S., Han, L., Wang, C., Liu, S., Simpson, E., Liu, Y., Wang, Y., Shou, W., et al. (2023) · Stem Cell Research & Therapy · doi:10.1186/s13287-023-03485-3 · Cited by 10
“For 3D embryoid body (EBs) differentiation, hiPSCs were differentiated toward CMs using our previously established protocol [25, 26].”
MethodSelf-citationALK1 Signaling in Human Cardiac Progenitor Cells Promotes a Pro-angiogenic Secretome
Moore, M. A., Ryzhov, S. V., Sawyer, D. B., Gartner, C. A., & Vary, C. (2024) · Journal of Cellular Signaling · doi:10.33696/signaling.5.119 · Cited by 9
“The ability of hHiPCs to form colonies is a common characteristic of therapeutic cells and identifies a subpopulation of epicardial cells that can be easily isolated from the adult heart [61–63].”
BackgroundRegenerative medicine in cardiovascular disease
Goto, T., Nakamura, Y., Ito, Y., & Miyagawa, S. (2024) · Regenerative Therapy · doi:10.1016/j.reth.2024.09.004 · Cited by 10
Lee, M. Y., Sun, B., Schliffke, S., Yue, Z., Ye, M., Paavola, J., Çağavi, E., Amos, P. J., Ren, Y., Ju, R., et al. (2011) · Stem Cell Research · doi:10.1016/j.scr.2011.08.004 · Cited by 9
“Commonly, during cardiac differentiation in ESCs, all cardiac phenotypes including nodal, atrial and ventricular cells can be detected in ESC cultures [11, 15].”
Characterization and comparison of embryonic stem cell-derived KDR+ cells with endothelial cells
Sun, X., Cheng, L., Duan, H., Lin, G., & Lu, G. (2012) · Microvascular Research · doi:10.1016/j.mvr.2012.06.003 · Cited by 9
Trends in cardiovascular engineering: Organizing the human heart
Tulloch, N. L., & Murry, C. E. (2013) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2013.04.001 · Cited by 10
“Two robust protocols, in particular, have been used to generate large numbers of human cardiomyocytes from human embryonic stem cells (Laflamme et al., 2007; Yang et al., 2008) and, more recently, from hiPSCs (Fig.”
InfluentialYeo, H. C., Ting, S., Brena, R. M., Koh, G., Chen, A., Toh, S. Q., Lim, Y. M., Oh, S. K. W., & Lee, D. (2016) · Scientific Reports · doi:10.1038/srep31068 · Cited by 10
Baio, J., Walden, R. C., Fuentes, T. I., Lee, C. C., Hasaniya, N. W. M. A., Bailey, L. L., & Kearns‐Jonker, M. (2017) · Transplantation Direct · doi:10.1097/txd.0000000000000667 · Cited by 9
Scalise, M., Marino, F., Salerno, L., Amato, N., Quercia, C., Siracusa, C., Filardo, A., Chiefalo, A., Pagano, L., Misdea, G., et al. (2023) · Cells · doi:10.3390/cells12131793 · Cited by 9
“Several approaches have been implemented to overcome this developmental block and further mature the hPSC-derived cardiomyocytes [20,38].”
MethodSzebényi, K., Erdei, Z., Péntek, A., Sebe, A., Orbán, T. I., Sarkadi, B., & Apáti, Á. (2011) · Personalized Medicine · doi:10.2217/pme.11.19 · Cited by 13
Turnbull, I. C., Lieu, D. K., Li, R. A., & Costa, K. D. (2012) · Drug Discovery Today Disease Models · doi:10.1016/j.ddmod.2012.11.001 · Cited by 9
Mesenchymal differentiation propensity of a human embryonic stem cell line
Pringle, S. A., Bari, C. D., Dell’Accio, F., Przyborski, S. A., Cooke, M. J., Minger, S. L., & Grigoriadis, A. E. (2011) · Cell Proliferation · doi:10.1111/j.1365-2184.2011.00744.x · Cited by 9
Aggregate and Microcarrier Cultures of Human Pluripotent Stem Cells in Stirred-Suspension Systems
Ashok, P., Fan, Y., Rostami, M. R., & Tzanakakis, E. S. (2015) · Methods in molecular biology · doi:10.1007/7651_2015_312 · Cited by 10
“Mesodermal cells are KDR/PGDFRα as well as C-KIT [13, 14].”
Gómez‐Vaquero, C., Martín, I., Loza, E., Carmona, L., Cortés, J. I., Narváez, J. A., Gañán, J. H., Alia, P. J., & Narváez, J. (2016) · PLoS ONE · doi:10.1371/journal.pone.0166691 · Cited by 9
Disease modeling of cardiac arrhythmias using human induced pluripotent stem cells
Liang, W., Gasparyan, L., Alqarawi, W., & Davis, D. R. (2019) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2019.1575359 · Cited by 11
High-throughput 3D screening for differentiation of hPSC-derived cell therapy candidates
Muckom, R. J., Bao, X., Tran, E., Chen, E., Murugappan, A., Dordick, J. S., Clark, D. S., & Schaffer, D. V. (2020) · Science Advances · doi:10.1126/sciadv.aaz1457 · Cited by 11
Eng, G. M., Lee, B. W., Radisic, M., & Vunjak‐Novakovic, G. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-398358-9.00038-0 · Cited by 14
Gao, M., Yang, J., Liu, G., Wei, R., Zhang, L., Wang, H., Wang, G., Gao, H., Chen, G., & Hong, T. (2012) · Peptides · doi:10.1016/j.peptides.2012.02.006 · Cited by 9
The use of stem cells for the repair of cardiac tissue in ischemic heart disease
Brenner, C., & Franz, W.-M. (2011) · Expert Review of Medical Devices · doi:10.1586/erd.10.78 · Cited by 9
Jyoti, S., & Tandon, S. (2015) · Human & Experimental Toxicology · doi:10.1177/0960327114564795 · Cited by 10
Monkeying around with cardiac progenitors: hope for the future
Li, Q., & Srivastava, D. (2010) · Journal of Clinical Investigation · doi:10.1172/jci42643 · Cited by 9
Yang, P. C.-M. (2012) · Circulation · doi:10.1161/circulationaha.112.119305 · Cited by 9
Odenkirk, M. T., Jostes, H. C., Francis, K. R., & Baker, E. S. (2025) · Molecular Omics · doi:10.1039/d4mo00261j · Cited by 8
A retinoic acid:YAP1 signaling axis controls atrial lineage commitment
Abraham, E., Kostina, A. S., Volmert, B. D., Roulé, T., Huang, L., Yu, J., Williams, A. E., Megill, E., Douglas, A., Pericak, O. M., et al. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.115687 · Cited by 8
Pallotta, I., Sun, B. Q., Lallos, G., Terrenoire, C., & Freytes, D. O. (2017) · Journal of Tissue Engineering and Regenerative Medicine · doi:10.1002/term.2460 · Cited by 8
“The PDGFRα+ progenitor population may be cardiac precursor cells (Yang et al., 2008) or precursors of smooth muscle cells and endothelial cells (Chong, Forte, & Harvey, 2014) known to contribute to the vascular and mesenchymal compartments of the heart.”
BackgroundSomatic Cell Reprogramming into Cardiovascular Lineages
Chen, J., Plonowska‐Hirschfeld, K. A., & Wu, S. M. (2014) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1177/1074248414527641 · Cited by 9
Li, L. K., Larabee, S. M., Chen, S., Basiri, L., Yamaguchi, S., Zakaria, A. M., & Gallicano, G. I. (2011) · Stem Cells and Development · doi:10.1089/scd.2011.0582 · Cited by 8
Reprogramming for cardiac regeneration
Raynaud, C. M., Ahmad, F. S., Allouba, M., Abou-Saleh, H., Lui, K. O., & Yacoub, M. H. (2014) · Global Cardiology Science and Practice · doi:10.5339/gcsp.2014.44 · Cited by 9
Maturation of Stem cell-derived Human Heart Tissue By Mimicking Fetal Heart Rate
Nunes, S. S., Miklas, J. W., & Radisic, M. (2013) · Future Cardiology · doi:10.2217/fca.13.71 · Cited by 8
Application of Patient-Specific iPSCs for Modelling and Treatment of X-Linked Cardiomyopathies
Zhang, J., Chou, O. H. I., Tse, Y.-L., Ng, K., & Tse, H. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22158132 · Cited by 8
Liu, J., Zhang, Y., Han, L., Guo, S., Wu, S., Doud, E. H., Wang, C., Chen, H., Rubart, M., Wan, J., et al. (2022) · Stem Cell Reports · doi:10.1016/j.stemcr.2022.01.014 · Cited by 12
Self-citationCardiovascular Regeneration via Stem Cells and Direct Reprogramming: A Review
Lee, C.-S., Kim, J., Cho, H., & Kim, H.-S. (2022) · Korean Circulation Journal · doi:10.4070/kcj.2022.0005 · Cited by 8
High‐Throughput Screening Assay for Embryoid Body Differentiation of Human Embryonic Stem Cells
Outten, J. T., Gadue, P. J., French, D. L., & Diamond, S. L. (2012) · Current Protocols in Stem Cell Biology · doi:10.1002/9780470151808.sc01d06s20 · Cited by 9
“Activin A and bFGF induce endoderm (D’Amour et al., 2006), BMP4 and bFGF induce mesoderm (Yang et al., 2008), and activin/ nodal (SB431542) and BMP4 (soluble BMPR1A) inhibition with bFGF induce ectoderm (Chambers et al., 2009).”
BackgroundProgramming cells for cardiac repair
Romagnuolo, R., & Laflamme, M. A. (2017) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2017.05.011 · Cited by 8
“com cardiac differentiation of hPSCs after their organization into EBs in suspension cultures [46].”
BackgroundPluripotent and Mesenchymal Stem Cells—Challenging Sources for Derivation of Myoblast
Archacka, K., Brzóska, E., Ciemerych, M. A., Czerwińska, A. M., Grabowska, I., Kowalski, K., & Zimowska, M. (2017) · Springer eBooks · doi:10.1007/978-3-319-70685-6_6 · Cited by 10
Zhang, R., Guo, T., Han, Y., Huang, H., Shi, J., Hu, J., Li, H., Wang, J., Saleem, A., Zhou, P., et al. (2020) · Journal of Biomedical Materials Research Part B Applied Biomaterials · doi:10.1002/jbm.b.34759 · Cited by 8
Tokuyama, T., Ahmed, R. E., Chanthra, N., Anzai, T., & Uosaki, H. (2021) · Biology · doi:10.3390/biology10100981 · Cited by 10
The Beat Goes On: Human Heart Muscle From Pluripotent Stem Cells
Eschenhagen, T. (2011) · Circulation Research · doi:10.1161/circresaha.111.248039 · Cited by 8
Hear the beat: decellularized mouse heart regenerated with human induced pluripotent stem cells
Lin, B., Lu, T., & Yang, L. (2014) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.2014.879039 · Cited by 11
Self-citationSpecial Issue on Tissue Engineering
Radisic, M., & Alsberg, E. (2017) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.7b00604 · Cited by 8
Human Cardiac Transcription Factor Networks
Varshney, A., Chahal, G., Santos, L., Stolper, J., Hallab, J. C., Nim, H. T., Nikolov, M., Yip, A., & Ramialison, M. (2021) · Systems Medicine · doi:10.1016/b978-0-12-801238-3.11597-1 · Cited by 7
Kohjitani, H., Koda, S., Himeno, Y., Makiyama, T., Yamamoto, Y., Yoshinaga, D., Wuriyanghai, Y., Kashiwa, A., Toyoda, F., Zhang, Y., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-23398-0 · Cited by 7
Differentiation of Pluripotent Stem Cells for Disease Modeling: Learning from Heart Development
Chi, C., Roland, T. J., & Song, K. (2024) · Pharmaceuticals · doi:10.3390/ph17030337 · Cited by 7
“Adding TGF-β s to the culture medium during ES differentiation enhances cardiac differentiation [151,152].”
BackgroundGaskell, T. L., Englund, M. C. O., & Hyllner, J. (2016) · Springer eBooks · doi:10.1007/978-3-319-27610-6_2 · Cited by 9
“influence of various cocktails of growth factors or small molecules in attempts to recapitulate heart development in vivo (Kehat et al. 2001; Yang et al. 2008).”
BackgroundIn vitro generation of immune cells from pluripotent stem cells
Vandekerckhove, B., Vanhee, S., Coppernolle, S. V., Snauwaert, S., Velghe, I., Taghon, T., Leclercq, G., Kerre, T., & Plum, J. (2010) · Frontiers in bioscience · doi:10.2741/3800 · Cited by 9
Cheng, I., Kaiser, D., Hübscher, D., Hasenfuss, G. P., Guan, K., & Schäfer, K. (2012) · Journal of Vascular Research · doi:10.1159/000332910 · Cited by 7
Pitrez, P. R., Rosa, S. C., Praça, C., & Ferreira, L. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.10.014 · Cited by 9
“Early differentiation of human PSCs is modulated by major signaling pathways: bone morphogenetic protein (BMP), transforming growth factor (TGF)-b/Activin/Nodal, WNT/b-catenin and fibroblast growth factor (FGF) [24] giving rise to cardiovascular lineage progenitors which can be differentiated into cardiomyocytes, endo…”
BackgroundParsons, X. H. (2013) · British Biotechnology Journal · doi:10.9734/bbj/2013/4309 · Cited by 7
“Although cell populations expressing stem/progenitor cell markers have been identified in postnatal hearts, the minuscule quantities and growing evidences indicating that they are not genuine heart cells have caused skepticism if they can potentially be harnessed for cardiac repair [78,105–110].”
BackgroundHuman Embryonic Stem Cells in Regenerative Medicine
Yabut, O., & Bernstein, H. S. (2011) · Humana Press eBooks · doi:10.1007/978-1-61779-322-6_2 · Cited by 7
Inducing Embryonic Stem Cells to Become Cardiomyocytes
Becker, A. M., Rubart, M., & Field, L. J. (2011) · Humana Press eBooks · doi:10.1007/978-1-61779-021-8_2 · Cited by 7
“Activin A, BMP4, bFGF, VEGF, and DKK1 treatment, followed by KDR/c-kit FACS, identified cardiovascular progenitor cells in human ESCs [51]”
BackgroundSelf-citationStem cells in pediatric cardiology
Patel, P., & Mital, S. R. (2013) · European Journal of Pediatrics · doi:10.1007/s00431-012-1920-4 · Cited by 8
“Third, and most importantly, the process of cardiac differentiation of human iPSCs recapitulates cardiac embryogenesis thereby providing an unparalleled opportunity to explore the impact of gene or environmental defects on early cardiac development [36].”
BackgroundBarbaric, I., Allison, T. F., Powles-Glover, N. S., Biga, V., & Andrews, P. W. (2015) · International Journal of High Throughput Screening · doi:10.2147/ijhts.s58113 · Cited by 9
“…through Activin A and bFGF treatment 54 using a stepwise differentiation protocol using Activin A, BMP4, FGF, vascular endothelial growth factor, and DKK1, 59 as well as the use of chemical inhibitors such as P203580 (P38 MAPK inhibitor) 60 and 5-aza-2 ′ -deoxy-cytidine to enhance specification.”
Hatani, T., Funakoshi, S., Deerinck, T. J., Bushong, E. A., Kimura, T., Takeshima, H., Ellisman, M. H., Hoshijima, M., & Yoshida, Y. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.10.020 · Cited by 7
Li, S., Chopra, A., Keung, W., Chan, C. W. Y., Costa, K. D., Kong, C., Hajjar, R. J., Chen, C. S., & Li, R. A. (2019) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00540.2018 · Cited by 7
Yan, Y., Liu, F., Dang, X., Zhou, R., & Liao, B. (2021) · Gene Expression Patterns · doi:10.1016/j.gep.2021.119184 · Cited by 7
Sougawa, N., Miyagawa, S., & Sawa, Y. (2021) · Methods in molecular biology · doi:10.1007/978-1-0716-1484-6_3 · Cited by 7
Zhao, Y., Eng, G. M., Lee, B. W., Radisic, M., & Vunjak‐Novakovic, G. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-818422-6.00033-2 · Cited by 7
Temporal Expression of Calcium Channel Subunits in Satellite Cells and Bone Marrow Mesenchymal Cells
Grajales, L., Lach, L. E., Janisch, P., Geenen, D. L., & García, J. (2014) · Stem Cell Reviews and Reports · doi:10.1007/s12015-014-9566-4 · Cited by 8
Yang, Y., Schumacher, A. M., Yang, Y., Liu, J., Shi, X., Hill, W., & Hu, T. C. (2011) · Magnetic Resonance in Medicine · doi:10.1002/mrm.22735 · Cited by 7
Advancements in Induced Pluripotent Stem Cell Technology for Cardiac Regenerative Medicine
Suh, C. Y., Wang, Z., Bártulos, Ó., & Qyang, Y. (2014) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1177/1074248414523676 · Cited by 8
Pluripotent Stem Cells and Their Dynamic Niche
Reinwald, Y., Bratt, J. A. J., & Haj, A. J. E. (2016) · InTech eBooks · doi:10.5772/62671 · Cited by 10
Metadata
- Authors
- Yang, L., Soonpaa, M. H., Adler, E. D., Roepke, T. K., Kattman, S. J., Kennedy, M., Henckaerts, E., Bonham, K., Abbott, G. W., Linden, R. M., Field, L. J., & Keller, G. M.
- Affiliations
- Icahn School of Medicine at Mount Sinai (US)
- Indiana University School of Medicine (US)
- Cornell University (US)
- University Health Network (CA)
- King's College London (GB)
- VistaGen Therapeutics (United States) (US)
- Corresponding author
- Keller, Gordon M.
- ORCID
- Venue
- Nature
- Published
- 2008-04-23
- Volume
- 453
- Issue
- 7194
- Pages
- 524-528
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2010417854
- Cited by
- 1,389
- References
- 30
- Citations by year
- 2026: 17 · 2025: 20 · 2024: 20 · 2023: 33 · 2022: 45 · 2021: 60 · 2020: 65 · 2019: 59 · 2018: 66 · 2017: 89 · 2016: 79 · 2015: 107 · 2014: 114 · 2013: 141 · 2012: 146
- FWCI
- 45.03
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Research Portal (King's College London) (submittedVersion)
- Lirias (submittedVersion)
- Funders
- National Institutes of Health
- National Heart, Lung, and Blood Institute (R01HL079275, R01HL083126)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Congenital heart defects research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
- Keywords
- human embryonic stem cells, cardiac progenitor cells, KDR, Flk-1, cardiomyocyte differentiation, endothelial differentiation, vascular smooth muscle cell differentiation, mesoderm specification, heart development, embryoid bodies, cell transplantation, cardiac regeneration, cardiovascular tissue engineering, lineage tracing, clonal origin, growth factor cocktail, activin A, BMP4, basic fibroblast growth factor
- MeSH terms
- Cell Differentiation, Cell Line, Humans, Fibroblast Growth Factor 2, Patch-Clamp Techniques, Proto-Oncogene Proteins c-kit, Cell Lineage, Bone Morphogenetic Proteins, Activins, Myocytes, Cardiac, Intercellular Signaling Peptides and Proteins, Vascular Endothelial Growth Factor Receptor-2, Vascular Endothelial Growth Factor A, Embryonic Stem Cells, Bone Morphogenetic Protein 4
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.